Comparison

Anti-µ-Opioid Receptor/OPRM1 (ext)-FITC European Partner

Item no. ALO-AOR-011-F-2x50ul
Manufacturer Alomone
Amount 2 x 50 ul
Quantity options 10 x 50 ul 15 ul 2 x 50 ul 50 ul 5 x 50 ul
Category
Type Antibody Polyclonal
Format Lyophilized
Applications FC
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host Rabbit
Isotype IgG
Conjugate/Tag FITC
Purity Affinity purified on immobilized antigen.
Formula PBS pH7.4, 1% BSA with 0.05% sodium azide
Sequence CSPAPGSWLNLSHVDGN, corresponding to amino acid residues 22-38 of the rat µ-Opioid receptor
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Shipping Condition Room temperature
Available
Specificity Polyclonal
Manufacturer - Type
Antibodies
Manufacturer - Applications
FC, LCI
Manufacturer - Category
Antibodies
Manufacturer - Targets
Mu-type opioid receptor, Opioid receptor B, MOR-1, MOP, Mu-opiate receptor
Manufacturer - Conjugate / Tag
Fluorescein isothiocyanate (FITC)
Country of Origin
Israel
Shipping Temperature
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Storage Conditions
Storage before Reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C - Storage after Reconstitution: The reconstituted solution can be stored at 4°C, protected from the light, for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
Manufacturer - Format
Lyophilized powder
Short description
A Rabbit Polyclonal Antibody to OPRM1 Conjugated to the Fluorescent Dye FITC
Description
Mu-type opioid receptor, Opioid receptor B, MOR-1, MOP, Mu-opiate receptor - A Rabbit Polyclonal Antibody to OPRM1 Conjugated to the Fluorescent Dye FITC
Clonality
Polyclonal
Homology
Mouse - identical; human - 15/17 amino acid residues identical
Standard quality control of each lot
Western blot analysis (unlabeled antibody, #AOR-011), and direct flow cytometry (labeled antibody).
Peptide confirmation
Confirmed by amino acid analysis and mass spectrometry
Reconstitution
15 µl or 50 µl double distilled water (DDW), depending on the sample size.
Antibody Concentration After Reconstitution
1 mg/ml
Preservative
1% BSA, 0.05% NaN3
Immunogen Location
Extracellular, N-terminus
Specificity
OPRM1
Immunogen source species
Rat
PH
7, 4
UNSPSC
41116161
Antigen Preadsorption Control
1 µg peptide per 1 µg antibody
Scientific Background
Endogenous opiates such as endorphins, endomorphins, and enkephalins, as well as opiate drugs (including morphine) exert their effects by binding to opioid receptors. Three "classic" types of opioid receptors have been identified: mu (µ)-opioid (MOP) receptor, delta (δ)-opioid (DOP) receptor, and kappa (κ)-opioid (KOP) receptor1. Recently, the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor was also described. Despite its significant sequence homology, its pharmacological profile differs greatly from those of the classic µ, δ, and κ receptors2.The opioid receptors belong to the G protein-coupled receptor (GPCR) superfamily whose members share a common structure of seven putative transmembrane domains, an extracellular amino terminus, a cytoplasmic carboxyl terminus, and a third intracellular loop important for binding G proteins1.All three receptors mediate opioid-induced analgesia. Supraspinal analgesia is mainly mediated by the µ-receptors, whereas µ-, δ-, and κ-receptors participate in the control of pain at the spinal level. These receptors also mediate the mood-altering properties of opioids3.Of the opioid receptors, the µ-opioid receptor has been the most extensively studied due to its important role in mediating the actions of morphine and other analgesic agents, as well as other addictive drugs such as heroin1. The µ-opioid receptors are expressed in the central nervous system (CNS) and in the peripherial nervous system4. The highest densities are found in the thalamus, caudate putamen, neocortex, amygdala, and other brain regions known to have well established roles in pain and analgesia5.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 x 50 ul
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close